Study guide
CBC, RBC Indices, Reticulocytes, and Anemia Patterns
ASCP MLT Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 ASCP MLT Exam Overview and Laboratory Operations
Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification
2 Chemistry, Urinalysis, and Body Fluid Interpretation
Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns
3 Hematology and Hemostasis
CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions
4 Blood Banking and Transfusion Practice
ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow
5 Microbiology Workups and Susceptibility Reasoning
Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting
6 Immunology, Integrated Cases, and Final Review
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation
CBC, RBC Indices, Reticulocytes, and Anemia Patterns
Key Takeaways Explain This Topic AI
The ASCP MLT guideline weights Hematology at 20-25%, so CBC interpretation and anemia pattern recognition deserve high-priority review.
RBC indices turn the CBC into a classification tool: MCV sizes the cell, MCH estimates hemoglobin per cell, MCHC reflects hemoglobin concentration, and RDW reflects size variation.
Reticulocytes separate underproduction anemia from marrow response to blood loss or hemolysis.
Microcytic, normocytic, and macrocytic anemia patterns should be tied to smear findings, iron studies, and reticulocyte response instead of memorized labels alone.
Spurious RBC results often reveal themselves through impossible index relationships, especially an unexpectedly high MCHC.
Last updated: May 2026
CBC Pattern Reading for MLT Hematology
The official ASCP MLT content guideline places Hematology at 20-25% of the total examination and includes hematology physiology, disease states, laboratory testing, and hemostasis. For the CBC portion, the MLT task is usually practical: recognize whether the numbers fit, calculate common indices, correlate them with a smear, and decide when a result needs review before release.
A complete blood count (CBC) is not one result. It is a set of related measurements. Hemoglobin and hematocrit describe oxygen-carrying mass. RBC count describes cell number. The indices describe average RBC size and hemoglobinization. RDW describes variation in size. The platelet and WBC parts of the CBC are interpreted separately, but RBC abnormalities can affect the whole report when nucleated RBCs, clots, agglutination, or fragments are present.
Core RBC formulas
- Index or calculation Formula What it tells you
- MCV (Hct % x 10) / RBC Average RBC volume in fL; low is microcytic, high is macrocytic
- MCH (Hgb g/dL x 10) / RBC Average hemoglobin mass per RBC in pg
- MCHC (Hgb g/dL x 100) / Hct % Hemoglobin concentration in packed RBCs
Corrected WBC WBC x 100 / (100 + nRBC per 100 WBC) Corrects WBC when significant nucleated RBCs are counted as WBCs
- Absolute reticulocyte count RBC x retic % with unit conversion Estimates marrow RBC release
- Corrected reticulocyte % retic % x patient Hct / 45 Adjusts retic percent for anemia severity
Use the ASCP exam-purpose reference ranges as a starting frame: RBC 4.00-6.00 x 10^6/uL, Hgb 12.0-18.0 g/dL, Hct 35-50%, MCV 76-100 fL, MCH 26-34 pg, MCHC 32-36 g/dL, RDW 11.5-14.5%, and reticulocytes 0.5-2.5% or 20-115 x 10^3/uL. Local clinical laboratories may use narrower sex- or age-specific ranges, but ASCP's composite ranges are the exam reference point.
First pass: does the CBC make physiologic sense?
A quick rule is the rule of three : RBC x 3 approximates Hgb, and Hgb x 3 approximates Hct in many normocytic, normochromic samples. It is only a screen, not a reporting rule. A major mismatch can suggest cold agglutinins, lipemia or icterus interfering with hemoglobin, RBC fragments, severe microcytosis, recent transfusion, or specimen problems.
A very high MCHC is especially useful because true MCHC above the usual range is uncommon. Spherocytes may mildly increase MCHC, but values such as 38-40 g/dL often point to analytic interference. Cold agglutinins can falsely lower RBC count while raising MCV and MCHC. The MLT response is to check flags, inspect the smear for agglutination, warm and rerun if required by procedure, and document the corrective action.
Classifying anemia by MCV and reticulocytes
Start with whether Hgb/Hct are low. Then use MCV to classify the anemia and reticulocytes to decide whether the marrow is responding.
Pattern Common MLT clues High-yield associations
Microcytic Low MCV, hypochromia, anisocytosis Iron deficiency, thalassemia, anemia of chronic inflammation, sideroblastic anemia
Normocytic with high retic Normal MCV, polychromasia, possible spherocytes or schistocytes Acute blood loss or hemolysis
Normocytic with low retic Normal MCV but poor marrow response Renal disease, chronic inflammation, aplastic or marrow failure patterns
Macrocytic megaloblastic High MCV, macro-ovalocytes, hypersegmented neutrophils Vitamin B12 or folate deficiency pattern
Macrocytic non-megaloblastic Round macrocytes or reticulocytosis, fewer hypersegmented neutrophils Liver disease, alcohol effect, hypothyroid pattern, recovery from hemolysis or bleeding
Iron deficiency usually shows microcytosis, hypochromia, increased RDW, low ferritin, and high total iron-binding capacity. Thalassemia trait can also be microcytic but often has many target cells, a relatively preserved or increased RBC count, and RDW that may be less striking. Anemia of chronic inflammation often has low serum iron with normal or increased ferritin and lower TIBC than iron deficiency.
Macrocytic anemia should not be called megaloblastic from MCV alone. Megaloblastic morphology includes macro-ovalocytes and hypersegmented neutrophils because nuclear maturation lags behind cytoplasmic maturation. Non-megaloblastic macrocytosis may come from liver disease, alcohol exposure, hypothyroidism, or reticulocytosis. Reticulocytes are larger than mature RBCs, so a hemolytic response can lift the MCV.
Smear clues that change the interpretation
Use morphology as evidence, not decoration. Schistocytes point toward fragmentation and can fit microangiopathic hemolysis, disseminated intravascular coagulation, mechanical valve injury, or severe burns depending on context. Spherocytes fit hereditary spherocytosis or warm autoimmune hemolysis. Target cells fit thalassemia, liver disease, hemoglobin C disease, and postsplenectomy patterns.
Teardrop cells suggest marrow distortion or infiltration when prominent. Howell-Jolly bodies suggest absent or decreased splenic function. Basophilic stippling can be seen with thalassemia, lead exposure, or disordered heme synthesis.
For MLT exam questions, expect one best answer from the data given. Do not overdiagnose from one number. A microcytic anemia with low ferritin and high TIBC is iron deficiency pattern. A normocytic anemia with high reticulocytes and high LDH is hemolysis or blood loss pattern. A macrocytic anemia with macro-ovalocytes and hypersegmented neutrophils is megaloblastic pattern.
Practical release mindset
Before reporting, ask: Do the indices agree with Hgb and Hct? Is MCHC plausible? Did the analyzer flag RBC agglutination, fragments, nucleated RBCs, or dimorphic RBCs? Does the smear support the automated result? If the answer is no, follow the local SOP for smear review, repeat analysis, correction, comment, or supervisor/pathologist escalation.